Related Experiment Video
Updated: Jun 26, 2026
06:07
Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
Published on: June 23, 2023
What causes cell death in Parkinson's disease?
Amitabh Gupta1, Valina L Dawson, Ted M Dawson
1Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Annals of Neurology
|January 8, 2009
Summary
Parkinson's disease (PD) lacks effective treatments. Recent genetic discoveries offer new therapeutic targets to slow, halt, or restore function by understanding PD-related gene mutation mechanisms.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Parkinson's disease (PD) currently has no proven neuroprotective or neurorestorative therapies.
- Advances in understanding PD genetics offer new therapeutic avenues.
- Identifying molecular mechanisms of gene mutations is key to developing treatments.
Purpose of the Study:
- To review recent advances in identifying novel therapeutic targets for Parkinson's disease.
- To explore how genetic discoveries inform mechanistic-based treatment strategies.
- To understand the link between gene mutations and neurodegeneration in PD.
Main Methods:
- Literature review of advances in Parkinson's disease genetics over the last decade.
- Analysis of molecular mechanisms underlying gene mutations associated with PD.
- Identification of potential therapeutic targets based on mechanistic insights.
Main Results:
- Numerous genetic discoveries have been made in the last decade regarding Parkinson's disease.
- Understanding the molecular basis of gene mutations provides insights into neurodegeneration.
- New targets for disease-modifying therapies are emerging from genetic research.
Conclusions:
- Genetic research provides a strong foundation for developing novel Parkinson's disease therapies.
- Mechanistic-based approaches targeting gene mutation pathways hold promise for slowing or halting PD progression.
- Future therapies may focus on neuroprotection, neurorestoration, and functional recovery in Parkinson's disease.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:30Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.